BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ProFibrix 

Acacialaan 7

Leiderdorp    2351 CA  The Netherlands
Phone: 31-0-621628475 Fax:


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
The Medicines Company (MDCO) Announces Positive Phase III Trial Results for Fibrocaps; Completes ProFibrix Acquisition 8/6/2013 6:49:25 AM    More...
The Medicines Company (MDCO) Signs Agreement to Acquire ProFibrix for Up to $10 Million 6/4/2013 6:50:39 AM    More...
ProFibrix Completes Patient Enrolment in Pivotal Phase III With Fibrocaps™ and Reports Positive Feedback From Surgical Community 4/4/2013 11:43:38 AM    More...
ProFibrix Passes Halfway Mark of Patient Enrolment in Pivotal Phase 3 With Fibrocaps™ and Successfully Concludes Safety Review Assessment 11/8/2012 10:21:43 AM    More...
ProFibrix to Present FibrocapsTM Phase II Data & Progress in Recombinant Fibrinogen Program at International Conferences 7/5/2012 10:54:59 AM    More...
ProFibrix US Phase II Study with FibrocapsTM Meets All Primary and Secondary Endpoints 1/5/2012 6:16:37 AM    More...
ProFibrix Phase II with FibrocapsTM Meets Primary Endpoint – On Track for Phase III in 2012 11/15/2011 6:18:44 AM    More...
ProFibrix Completes Enrollment of Phase II Studies with Lead Hemostasis Product FibrocapsTM and Targets Start of Phase III in H1 2012 9/13/2011 10:18:25 AM    More...
ProFibrix Raises $22M to Progress Fibrocaps Topical Sealant into Phase III 5/4/2011 8:29:10 AM    More...
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 3/11/2010 8:21:09 AM    More...
12